33486 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

States .............................................................. Weekly (Automated) ....................................... 50 52 20/60 

States .............................................................. Weekly (Non- automated) .............................. 10 52 2 

States .............................................................. Weekly (MMG Implementation) ..................... 50 52 4 

States .............................................................. Annual ............................................................ 50 1 75 

States .............................................................. One-time Addition of Diseases and Data Elements.50 1 1 

Territories ........................................................ Weekly (Automated) ....................................... 5 52 20/60 

Territories ........................................................ Weekly, Quarterly Non-automated) ............... 5 56 20/60 

Territories ........................................................ Weekly (MMG Implementation) ..................... 5 52 4 

Territories ........................................................ Annual ............................................................ 5 1 5 

Territories ........................................................ One-time Addition of Diseases and Data Elements.5 1 1 

Freely Associated States ................................ Weekly (Automated) ....................................... 3 52 20/60 

Freely Associated States ................................ Weekly, Quarterly (Non-automated) .............. 3 56 20/60 

Freely Associated States ................................ Annual ............................................................ 3 1 1

Freely Associated States ................................ One-time Addition of Diseases and Data Elements.3 1 12 

Cities ............................................................... Weekly (Automated) ....................................... 2 52 20/60 

Cities ............................................................... Weekly (Non-automated) ............................... 2 52 2 

Cities ............................................................... Weekly (MMG Implementation) ..................... 2 52 4 

Cities ............................................................... Annual ............................................................ 2 1 75 

Cities ............................................................... One-time Addition of Diseases and Data Elements.2 1 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–11769 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the CDC/HRSA 

Advisory Committee on HIV, Viral 

Hepatitis and STD Prevention and 

Treatment (CHACHSPT) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

CDC/HRSA Advisory Committee on 

HIV, Viral Hepatitis and STD Prevention 

and Treatment (CHACHSPT). The 

CHACHSPT consists of 18 experts in 

fields associated with public health; 

epidemiology; laboratory practice; 

immunology; infectious diseases; drug 

abuse; behavioral science; health 

education; healthcare delivery; state 

health programs; clinical care; 

preventive health; medical education; 

health services and clinical research; 

and healthcare financing, who are 

selected by the Secretary of the U.S. 

Department of Health and Human 

Services (HHS). 

DATES: Nominations for membership on 

the CHACHSPT must be received no 

later than October 1, 2022. Packages 

received after this time will not be 

considered for the current membership 

cycle. 

ADDRESSES: All nominations should be 

electronically mailed to nchhstppolicy@

cdc.gov with the subject line of ‘‘CHAC 

2023 Nomination.’’ 

FOR FURTHER INFORMATION CONTACT: 

Marah Condit, MS, Committee 

Management Lead, National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention, CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, Georgia 

30329–4027; Telephone: (404) 639– 

3423; Email: MCondit@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

Secretary of HHS, and by delegation, the 

CDC Director and the Administrator, 

Health Resources and Services 

Administration (HRSA), are authorized 

by the Public Health Service Act to: (1) 

Conduct, encourage, cooperate with, 

and assist other appropriate public 

health authorities, scientific 

institutions, and scientists in the 

conduct of research, investigations, 

experiments, demonstrations, and 

studies related to the cases, diagnosis, 

treatment, control, and prevention of 

physical and mental diseases, and other 

impairments; (2) assist states and their 

political subdivisions in preventing, 

suppressing, and treating communicable 

diseases and other preventable 

conditions and in promoting health and 

well-being; (3) assist public and 

nonprofit private entities in preventing, 

controlling, and treating sexually 

transmitted diseases (STDs), including 

the human immunodeficiency virus 

(HIV); (4) improve health and achieve 

health equity through access to quality 

services and a skilled health workforce 

and innovative programs; (5) support 

healthcare services to persons living 

with or at risk for HIV, viral hepatitis, 

and other STDs; and (6) advance the 

education of health professionals and 

the public from HIV, viral hepatitis, and 

other STDs. 

CHACHSPT meets at least two times 

each calendar year, or at the discretion 

of the Designated Federal Officers in 

consultation with the CHACHSPT cochairs. 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. The 

CHACHSPT charter stipulates that the 

Committee shall include representation 

of persons with HIV and other affected 

populations; state and local health and 

education agencies; HIV/viral hepatitis/ 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33487 

STD community-based organizations; 

and the ethics or faith-based 

community. At least four members shall 

be persons with HIV. 

Committee members are Special 

Government Employees (SGEs), 

requiring the filing of financial 

disclosure reports at the beginning of 

and annually during their terms. 

Individuals who are selected for 

appointment will be required to provide 

detailed information regarding their 

financial interests and, for example, any 

work they do for the federal government 

through research grants or contracts. 

Disclosure of this information is 

required in order for CDC ethics officials 

to determine whether there is a conflict 

between the SGE’s public duties as 

members of CHACHSPT and their 

private interests, including an 

appearance of a loss of impartiality as 

defined by federal laws and regulations, 

and to identify any required remedial 

action needed to address the potential 

conflict. CDC and HRSA review 

potential candidates for CHACHSPT 

membership when a vacancy arises and 

provide a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. CDC and HRSA each 

publishes a Federal Register notice and 

will be using a joint process to nominate 

nominees on a rolling basis; thus, 

applications received by CDC will be 

shared with HRSA for consideration. 

Therefore, potential candidates need 

only apply in response to one of the 

Federal Register notices. HHS notifies 

selected candidates of their 

appointment near the start of the term 

in December, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

SGE nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Candidates 

should submit the following items: 

D A letter of interest or personal 

statement from the nominee stating how 

their expertise would inform the work 

of CHACHSPT 

D A biographical sketch of the 

nominee (500 words or fewer) 

D Current curriculum vitae or resume, 

including complete contact information 

(telephone numbers, mailing address, 

email address) 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. Candidates 

may submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, Food and 

Drug Administration). 

Nominations may be submitted 

directly by the individual seeking 

nomination or by the person/ 

organization recommending the 

candidate. CDC and HRSA will collect 

and retain nominations received for up 

to two years to create a pool of potential 

CHACHSPT nominees. When a vacancy 

occurs, CDC and HRSA will review 

nominations and may contact nominees 

at that time. 

Appointments shall be made without 

discrimination on the basis of age, race, 

ethnicity, gender, sexual orientation, 

gender identity, HIV status, disability, 

and cultural, religious, or 

socioeconomic status. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–11815 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–22–0612; Docket No. CDC–2022– 

0074] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Well-Integrated 

Screening and Evaluation for Women 

Across the Nation Reporting System 

(WISEWOMAN). The WISEWOMAN 

program is designed to prevent, detect, 

and control, hypertension and other 

cardiovascular disease (CVD) risk 

factors through services such as health 

coaching, and evidence informed 

lifestyle programs, which are tailored 

for individual and group behavior 

change. 

DATES: CDC must receive written 

comments on or before August 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0074 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 


jspears on DSK121TN23PROD with NOTICES1